Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8129220 | 0.91 | CCNE1 (0.36) | CCNE1CDK2GSK3BNPC1RAB9A | |
| SCHEMBL1128725 | 0.91 | CCNE1 (0.36) | CCNE1CDK2GSK3BNPC1RAB9A | |
| SCHEMBL2624001 | 0.91 | CCNE1 (0.36) | CCNE1CDK2GSK3BNPC1RAB9A | |
| SCHEMBL16575072 | 0.91 | CCNE1 (0.36) | CCNE1CDK2GSK3BNPC1RAB9A | |
| SCHEMBL7875278 | 0.91 | CCNE1 (0.36) | CCNE1CDK2GSK3BNPC1RAB9A | |
| SCHEMBL14731660 | 0.89 | CCNE1 (0.36) | CCNE1CDK2GSK3BMGLL | |
| SCHEMBL14864657 | 0.89 | CCNE1 (0.36) | CCNE1CDK2GSK3BMGLL | |
| SCHEMBL12048372 | 0.89 | CCNE1 (0.36) | CCNE1CDK2GSK3BMGLL | |
| SCHEMBL20469204 | 0.88 | CCNE1 (0.38) | CCNE1CDK2GSK3BMGLL | |
| SCHEMBL19650290 | 0.86 | CCNE1 (0.35) | CCNE1CDK2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1270642-B1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KIRIN CO LTD (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-7691367-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20030219404-A1 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
| EP-1270642-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030219404-A1 | Branched polyalkylene glycols | LNPEP, ANPEP, BCAT1 | CCNE1 2564/4885CDK2 4776/4885GSK3B 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.